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Christian Münz*
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Endocytosis bymyeloid antigen presenting cells such as dendritic cells andmacrophages
regulates both antigen processing and major histocompatibility complex (MHC) molecule
trafficking during antigen presentation. The molecular machinery of macroautophagy, a
catabolic pathway that delivers cytoplasmic constituents to lysosomal degradation, has
recently been found to modulate both MHC class I internalization and phagocytosis of
antigens for efficient MHC class II presentation. In this review, I will discuss the respective
studies and how these alternative pathways of macroautophagy protein usage differ
from their canonical functions. A better understanding of these additional functions
of the macroautophagy machinery should allow us to interpret biological effects of
macroautophagy protein deficiencies more comprehensively and to therapeutically target
the different pathways which utilize the molecular machinery of macroautophagy.
Keywords: LC3-associated phagocytosis (LAP), MHC class I, MHC (HLA) class II proteins, Phagocytosis,
autophagy (macroautophagy)
INTRODUCTION
Adaptive immune responses are coordinated and in part executed by T cells. Their activation
requires the presentation of non-self peptides on major histocompatibility complex (MHC)
molecules (1, 2). These peptides originate from the main proteolytic machineries in cells with
the proteasome mainly responsible to produce MHC class I ligands to stimulate CD8+ T cells
and lysosomal proteases, like cathepsins, predominantly generating MHC class II ligands. These
proteolytic machineries do not discriminate between self and non-self, including pathogen derived
proteins, but central (e.g., clonal T cell deletion) and peripheral (e.g., regulatory T cells) tolerance
mechanisms prevent most T cell activation by complexes of self-peptides plus MHC molecules.
Proteasome products reach MHC class I molecules mainly after import into the endoplasmic
reticulum (ER) via the transporter associated with antigen processing (TAP), where they are loaded
onto co-translationally inserted MHC class I molecules in the MHC class I loading complex
containing chaperones and protein disulfide isomerases (1). MHC class I molecules with their
octa- to nonameric peptide ligands get then transported to the cell surface for interaction with
the T cell receptor (TCR) and CD8 co-receptor of CD8+ T cells. The longer MHC class II ligands,
often around 15 amino acid long peptides, are primarily generated by lysosomal proteolysis and
loaded in late endosomal compartments, that often present as multivesicular bodies (MVBs),
called MIICs, onto MHC class II molecules (2). These reach MIICs under the guidance of the
invariant chain (Ii) chaperone, which is then degraded by lysosomal proteases and the final Ii
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peptide remnant is exchanged for high affinity peptide ligands
with the help of the HLA-DM chaperone. The resulting
complexes of MHC class II molecules and their peptide ligands
then gets transported to the cell membrane for interaction with
the TCR and CD4 co-receptor of CD4+ T cells. According to
these cell biological requirements for MHC class I and II ligand
generation, CD8+ T cells recognize mainly intracellular antigens,
and CD4+ T cells extracellular antigens after their endocytosis
into late endosomes. However, alternative pathways exist for
access to proteasomes and lysosomal proteases in MIICs, namely
mechanistically poorly defined escape from endosomes during
MHC class I cross-presentation, recently coined type 1 cross-
presentation, and cytoplasmic constituent delivery to MIICs via
autophagy for MHC class II presentation, recently coined type 2
cross-presentation (3).
Autophagy consists of at least three pathways, micro-
autophagy, chaperone-mediated autophagy andmacroautophagy
(4, 5). So far, only chaperone-mediated and macroautophagy
have been implicated in antigen processing for MHC class
II presentation (6–9). However, microautophagy also delivers
cytoplasmic material to MVBs (10–13) and, thereby, might also
contribute to MHC class II presentation of intracellular antigens.
While chaperone-mediated autophagy utilizes LAMP2A and
cytosolic as well as lysosomal chaperones to transport proteins
with a KFERQ-like signal peptide across lysosomal and
possibly MVB membranes, macroautophagy employs more than
30 autophagy-related gene (atg) products to build double-
membrane surrounded autophagosomes and regulate their
fusion with lysosomes and late endosomes, including MVBs
(5, 14). The macroautophagy machinery mainly consists of
five complexes. The ULK1/Atg1 complex integrates metabolic
cues. It is relieved of its inhibition by mTOR and activated
via phosphorylation by the AMP-activated protein kinase
(AMPK) during starvation. The ULK1/Atg1 complex itself then
phosphorylates the VPS34 PI3 kinase complex containing Atg14
on its Beclin-1/Atg6 component, which in turn phosphorylates
membranes at which autophagosome formation is initiated, the
so called phagophore. Via PI3P the LC3/Atg8 lipidation complex
is recruited which consists of Atg5, 12, and 16L1 and conjugates
the ubiquitin-like Atg8 proteins, including LC3B/Atg8 and
GABARAP/Atg8, to phosphatidylethanolamine (PE) at the
phagophore. LC3/Atg8 lipidation then allows for membrane
elongation and substrate recruitment, either by directly binding
proteins that contain LC3-interacting regions (LIRs) or adaptors
that include LIRs and ubiquitin-binding domains to deliver
ubiquitinated aggregates, damaged organelles or pathogens
into autophagosomes. A fourth complex, that also facilitates
endosome maturation, containing VPS34, Beclin-1/Atg6, and
UVRAG then regulates fusion with lysosomes, which is executed
by the HOPS complex, Rab7 and syntaxin 17 (STX17). While
the Atg4 protease recycles LC3/Atg8 proteins from the outer
autophagosomal membrane upon vesicle completion, LC3/Atg8
on the inner autophagosomal membrane and its cargo including
ubiquitin-binding LIR adaptors like sequestosome/p62 are then
degraded by lysosomes. This highly sophisticated machinery
of membrane tagging by phosphorylation and then LC3/Atg8
protein conjugation that is used to generate autophagosomes
and regulate their fusion with other membrane compartments,
is, however, also used for alternative functions including the
regulation of endocytosis. This alternative use of the Atg
machinery will be discussed in this review.
RECEPTOR INTERNALIZATION VIA
LC3/ATG8 BINDING PROTEINS
The first protein for which an involvement of the
macroautophagy machinery for its internalization was
discovered is the amyloid precursor protein (APP) (15–17).
APP proteolysis gives rise to Aβ peptide, the main component of
extracellular proteaneous plaques in the central nervous system
of patients with Alzheimer’s disease (18). It was noted that
stimulation of the macroautophagy machinery stimulates APP
degradation in a fashion that neurodegenerative Aβ peptides are
not produced (15). This protective APP degradation depends
on the membrane conjugation machinery of LC3/Atg8 (16)
as well as Beclin-1/Atg6 (17). However, lipidated LC3/Atg8
does not recruit APP itself, but rather components of the
clathrin dependent internalization machinery, primarily
the adaptor protein complex 2 (AP2) (16) (Figure 1). Its
AP2A1 subunit contains a LIR motif, which was found to be
required for its binding to LC3. Boosting the macroautophagy
machinery via starvation or mTOR inhibition increased APP
internalization and degradation, and this process was inhibited
by RNA silencing of Atg5 (16). In addition to AP2A1, another
component of clathrin mediated endocytosis, namely clathrin
itself, also contains another LIR motif (19). Furthermore, APP
binds directly to Beclin-1/Atg6 via APP’s evolutionary conserved
domain (ECD) (17). This binding facilitates internalization
via the recruitment of the VPS34, Beclin-1/Atg6 and UVRAG
containing complex that enhances endosome maturation.
Thus, both binding of the clathrin dependent internalization
machinery to LC3/Atg8 that is coupled to the cell membrane and
Beclin-1/Atg6 binding to APP itself facilitates internalization and
degradation of the Aβ precursor and thereby inhibits amyloid
generation.
This enhanced internalization with the support of the
macroautophagy machinery is also hijacked by viruses
(Figure 1). The single stranded RNA virus ECHO (enteric
cytopathic human orphan) virus 7 of the picornaviridae family
was shown to require core components of macroautophagy for its
clathrin dependent internalization (20). RNA silencing of Beclin-
1/Atg6, Atg12, Atg14, Atg16, or LC3/Atg8 inhibited echovirus
7 entry prior to uncoating. Of these Atg16L1 was required for
echovirus internalization from the cell membrane of intestinal
epithelial cells, while attachment was unchanged. Furthermore,
the double stranded DNA virus white spot syndrome virus
(WSSV) of the Nimaviridae family requires GABARAP/Atg8
for clathrin mediated entry into crayfish cells (21). During entry
WSSV colocalized with GABARAP/Atg8 at the cell membrane.
Thus, echovirus 7 and WSSV seem to use clathrin mediated
endocytosis for surface internalization and this process is
facilitated by LC3/Atg8 and GABARAP/Atg8 conjugation to the
Frontiers in Immunology | www.frontiersin.org 2 November 2018 | Volume 9 | Article 2765
Münz Atg Proteins During Endocytosis
FIGURE 1 | Support of the macroautophagy machinery for receptor and virus internalization. MHC class I molecules, Alzheimer precursor protein (APP) and the two
viruses Echovirus 7 (ECHO) and white spot syndrome virus (WSSV) seem to utilize LC3/Atg8 or GABARAP/Atg8 lipidation of the cell membrane for more efficient
clathrin dependent internalization. For MHC class I molecules, LC3/Atg8 (LC3) mediated recruitment of the adaptor associated kinase 1 (AAK1), for APP, LC3/Atg8
binding of adaptor protein complex 2 (AP2) and direct binding to Beclin-1/Atg6, and for Echovirus 7 and WSSV, Atg16L1 and GABARAP/Atg8, respectively, have
been implicated in their internalization from the cell membrane. While this internalization leads to lysosomal degradation for MHC class I molecules and APP, the two
viruses escape to the cytosol from the respective endosomes. This figure was created in part with modified Servier Medical Art templates, which are licensed under a
Creative Commons Attribution 3.0 Unported License: https://smart.servier.com.
cell membrane, which might support recruitment of the clathrin
mediated endocytosis machinery.
THE ROLE OF ATG ASSISTED
ENDOCYTOSIS FOR MHC CLASS I
RESTRICTED ANTIGEN PRESENTATION
The internalization mechanism that benefits from Atg8 ortholog
mediated recruitment of components of the clathrin mediated
endocytosis machinery seems to also influence both classical
and non-classical MHC class I molecules (22, 23). In mice that
are deficient in the LC3/Atg8 lipidation complex components
Atg5 or Atg7 in their dendritic cells and some macrophage
populations, these myeloid cells have increased classical MHC
class Ia (H2-Kb and H2-Db) and non-classical MHC class Ib
(CD1d) surface expression levels. While these molecules are
transported to the cell surface at similar rate in Atg5 or Atg7
deficient cells, their internalization is significantly attenuated.
Other surface molecules like MHC class II, CD86 and CD40,
as well as MHC class I on B and T cells were not affected by
Atg5 or Atg7 deficiency in dendritic cells and some macrophages
(22–24). In immunoprecipitation experiments it was found that
the adaptor associated kinase 1 (AAK1) interacts with MHC
class Ia molecules less efficiently in the absence of Atg5 or
Atg7 (22). This kinase phosphorylates the µ subunit of the
AP2 complex (AP2M1) for more efficient clathrin mediated
endocytosis (25, 26). AAK1 also associates with LC3/Atg8
and contains predicted LIR motifs, suggesting that LC3/Atg8
lipidation at the plasma membrane localizes AAK1 in proximity
to MHC class I molecules for their more efficient internalization
(Figure 1). Accordingly, RNA silencing of AAK1 stabilizes
MHC class Ia molecules on the surface of mouse dendritic
cells (22). This MHC class I stabilization is of functional
relevance because influenza and lymphocytic choriomeningitis
virus (LCMV) specific CD8+ T cell responses are more efficiently
primed and/or expanded in mice with Atg5 deficiency in their
dendritic cells and some macrophage compartments, including
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alveolar macrophages (22). Influenza infected Atg5 deficient
dendritic cells also stimulate virus specific CD8+ T cells more
efficiently in vitro (22). The increased CD8+ T cell expansion in
mice with Atg5 or Atg7 deficiency in dendritic cells and some
macrophage populations also correlates with improved control
of viral titers and pathology in the influenza infected mice (22).
Similarly, Atg5 or Atg7 deficiency in macrophages rescues mice
from influenza induced pathology only after priming of adaptive
immune responses (10 days post-infection), while components
of the ULK1/Atg1 complex and the VPS34 PI3 kinase complex,
Fip200 and Atg14, are also required for the influenza induced
pathology during innate immunity at earlier timepoints (27).
In addition to this regulation of CD8+ T cell responses by
altered classical MHC class Ia internalization, NKT cell responses
that are restricted by the non-classical MHC class Ib molecule
CD1d are also altered in mice with Atg5 deficiency in dendritic
cells and some macrophage populations (23). Invariant NKT
cells recognize phospholipids on CD1d molecules (28). CD1d
accumulation on the surface of Atg5 deficient dendritic cells
leads to increased α-galactosylceramide (αGalCer) presentation
to NKT cells in vitro, and αGalCer injection leads to elevated
cytokine production in mice with Atg5 deficiency in dendritic
cells and some macrophage populations (23). Furthermore,
the pathogen Sphingomonas paucimobilis, which is exquisitely
sensitive to NKT cell mediated immune control during early
infection, reached lower bacterial loads associated with higher
cytokine production in the absence of Atg5 in dendritic cells
and some macrophages (23). These findings suggest that also
NKT cell responses are elevated in the absence of efficient
CD1d internalization that is supported by components of the
macroautophay machinery.
While endogenous antigen presentation by MHC class I
molecules seems to be increased in the absence of LC3/Atg8
lipidation, cross-presentation of exogenous antigens might be
compromised (29, 30). Indeed, the pool of MHC class I molecules
that is internalized into early endosomes of dendritic cells has
been suggested to be required for efficient cross-presentation
(31). Dendritic cells with VPS34 deficiency displayed increased
LCMV derived antigen presentation on MHC class I molecules
to CD8+ T cells, but failed to cross-present cell associated
ovalbumin efficiently (29, 30). Accordingly, mice with VPS34
deficiency in their dendritic cells and some macrophage
populations were more susceptible to challenge with B16
melanoma cells (30). This might suggest that loss of Atg
supported MHC class I internalization improves endogenous
antigen presentation, but inhibits cross-presentation to CD8+ T
cells.
LC3 ASSOCIATED PHAGOCYTOSIS (LAP)
In addition to LC3/Atg8 lipidation events at the cell membrane
that might support receptor as well as virus internalization, such
modifications have also been found to take place at endosomal
membranes (32, 33). The respective process was coined LC3
associated phagocytosis or LAP (32). It depends on the VPS34
and LC3/Atg8 lipidation complexes, but does not require the
ULK1/Atg1 complex (34). This machinery gets engaged when
extracellular material is phagocytosed that binds to distinct
receptors, including the pathogen associated molecular pattern
receptor toll-like receptor 2 (TLR2), antibody Fc receptors, the
C-type lectin Dectin-1 and the apoptotic body receptor TIM4
(32, 33, 35, 36) (Figure 2). VPS34 then introduces PI3P marks
on the phagosomal membrane, which allow the recruitment of
NADPH oxidase 2 (NOX2), whose reactive oxygen species (ROS)
generation is required for LAP (33, 34, 37). So far it is unclear
how ROS production by NOX2 regulates LAP, but macrophages
of chronic granulomatous disease (CGD) patients with defined
NOX2 mutations are not able to form LAP phagosomes after
TLR2 ligand internalization (33). The LC3/Atg8 lipidation
complex can be recruited to phagosomal membranes via the
WD40 domain of Atg16L1, which is not present in yeast Atg16
and might be an adaptation in higher eukaryotes to allow
for LAP (38). How this WD40 domain, however, recognizes
phagosomes that are in need of LC3/Atg8 modification remains
unclear. Nevertheless, Atg16L1 mediated recruitment of Atg5
and Atg12 then allows LC3/Atg8 conjugation to the cytosolic
side of phagosomes and these membrane tags are only removed
prior to phagosome fusion with lysosomes and MIICs (32,
33). LC3/Atg8 conjugation to phagosomes influences their
fate differently depending on the cellular background. While
it accelerates fusion with lysosomes, possibly by improving
endosome transport along microtubules and recruitment of the
fusion machinery, in mouse macrophages (39–41), LC3/Atg8
attenuates phagosome maturation and fusion with lysosomes
in human macrophages and monocyte-derived dendritic cells
(33). In plasmacytoid dendritic cells LC3/Atg8 seems to divert
phagosomes to TLR containing endosomes for efficient type I
interferon production after phagocytosed pathogen sensing (42).
Therefore, LAP seems to regulate endocytosis to adapt the fate
of the internalized cargo to the functional needs of the respective
phagocyte.
THE ROLE OF LAP DURING MHC CLASS II
RESTRICTED ANTIGEN PRESENTATION
Irrespective of the different kinetics of LC3 associated phagosome
fusion with lysosomes in human and mouse macrophages, in
both species LAP seems to enhance MHC class II restricted
antigen presentation (33, 35) (Figure 2). This was shown for
Candida albicans antigens in human macrophages and for
ovalbumin expressed in Saccharomyces cerevisiae in mouse
macrophages. Accordingly, exogenous antigen presentation on
MHC class II molecules to CD4+ T cells is also compromised
in mice with Atg5 deficiency in dendritic cells and some
macrophage populations (24). This also extends to autoantigens,
because experimental autoimmune encephalomyelitis (EAE)
upon myelin oligodendrocyte glycoprotein (MOG) specific
CD4+ T cell transfer is severely attenuated in mice with Atg5
deficiency in dendritic cells and some macrophage populations
(43). The respective dendritic cells are less efficient in processing
apoptotic MOG expressing oligodendrocytes for MHC class II
presentation to CD4+ T cells also in vitro. Commensal specific
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FIGURE 2 | LC3-associated phagocytosis (LAP) of antigens for improved MHC class II presentation. Phagocytosis of ligands for toll-like receptor 2 (TLR2), Dectin-1,
T-cell immunoglobulin and mucin domain-containing molecule 4 (TIM4) or antibody Fc receptors (FcR) leads to LC3/Atg8 conjugation to the cytosolic side of the
phagosomal membrane in a process called LC3-associated phagocytosis (LAP). Presumably prior to LC3 conjugation this membrane is modified by the PI3 kinase
(PI3K) to recruit NADPH oxidase 2 (NOX2), whose reactive oxygen species (ROS) production is required for LAP. The cargo of LC3/Atg8-associated phagosomes is
then more efficiently processed for prolonged antigen presentation on MHC class II molecules (MHC class II) which are loaded with lysosomal degradation products in
MHC class II containing compartments (MIICs) with the help of the chaperone HLA-DM. This figure was created in part with modified Servier Medical Art templates,
which are licensed under a Creative Commons Attribution 3.0 Unported License: https://smart.servier.com.
regulatory CD4+ T cells are also less well-induced in mice with
Atg16L1 deficiency in dendritic cells and some macrophage
compartments (44). Atg16L1 mutations are associated with
inflammatory bowel disease (IBD) in humans and patients with
such mutations have a decreased frequency of regulatory CD4+
T cells. Accordingly, mice with Atg16L1 deficient dendritic
cells and some macrophage populations develop inflammatory
bowel disease. In this study, the missing regulatory CD4+ T
cell induction was proposed to be mediated by outer membrane
vesicles (OMVs) of commensals. Similarly, mice that lack
LAP components in their macrophages were less able to clear
apoptotic cells, which led to the induction of autoantibodies
resulting in a lupus erythematosus like systemic autoimmunity
(45). Interestingly, this phenotype was observed in macrophage
deficiencies in Atg5, Atg7, Beclin-1/Atg6 or NOX2, but not
affected by loss of the ULK1/Atg1 complex components ULK1 or
Fip200. In this experimental system inefficient regulatory CD4+
T cell induction could have also contributed to the observed
autoimmune phenotype. Therefore, LAP supports anti-fungal,
autoimmune and regulatory CD4+ T cell responses in vitro and
in vivo by regulating endocytosed antigen processing for MHC
class II presentation.
CONCLUSIONS
The above summarized studies suggest that the macroautophagy
machinery fulfills important functions for the optimization
of endocytosis. So far two stages of endocytosis have been
found to be affected by deficiencies in the LC3/Atg8 lipidation
machinery, namely early internalization from the membrane,
presumably by a more efficient recruitment of the clathrin
dependent internalization machinery, and governing phagosome
fate by LC3/Atg8 conjugation to the cytosolic side of these
vesicles during LAP (46). The ability of the macroautophagy
machinery to conjugate LC3/Atg8 to other membranes than
autophagosomes has already been realized by Yoshinori Ohsumi,
who received for the discovery of the atg genes the Nobel prize
for physiology and medicine in 2016. He observed in yeast
that was deficient in the Atg4 protease that cleaves LC3/Atg8
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from the outer membrane of completed autophagosomes, and
that was transgenic for C-terminally truncated Atg8 which is
ready for conjugation to PE that LC3/Atg8 could be found
on lysosomal, endosomal and ER membranes (47). These
findings suggested that LC3/Atg8 deconjugation by Atg4 restricts
this membrane tag to autophagosomes in yeast and that any
regulatory mechanism of Atg4 mediated deconjugation would
allow LC3/Atg8 to be used for other membrane trafficking
functions. The identification of such regulatory mechanisms
that allows LC3/Atg8 lipidation to be retained at endosome
membranes and then used for phagocytosis should clarify in the
future how themacroautophagymachinery can fulfill its different
tasks during intracellular and extracellular cargo degradation in
lysosomes and MIICs.
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